Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial.

Lancet · 2019 · PMC6346082 · PMID 30696573

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

of borderline significanceno p-value reported

The prevalence of pre-eclampsia or pregnancy loss, or both, was 33% in the calcium group and 41% in the placebo group (RR 0·82 [95% CI 0·66–1·00]; p=0·050), which was of borderline significance.

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.